Robuta

As a CDMO, we care about your priorities, from product development to commercial manufacturing. View the full list AGC Biologics services and solutions

ACG Biologics announced agreement with Asahi Kasei Pharma Corporation to produce clinical drug substance for antibody-based therapies at our Seattle site

AGC Biologics operates multiple mammalian and microbial cGMP manufacturing lines and a variety of scales at our facilities in Copenhagen, Denmark.

AGC Biologics has entered a service agreement with Medigene AG to support the development of a next-generation autologous T-Cell therapy for solid cancers.

Our multi-purpose, highly-efficient Chiba microbial, mammalian, and plasmid DNA facility is designed for flexibility and high-quality production.

Medical Monitoring for Drugs and Biologics Foundational course covering the essential components of medical monitoring. View this course at CITI Program.

Our global facility network includes world-class cGMP facilities in the US, Europe and Asia, offering process development, at the scale you need.

Nov 24, 2025 - Over the past decade, biologics have transformed the treatment of chronic diseases - from cancer to metabolic and autoimmune disorders. Yet identifying...

Come Join AGC Biologics' Seattle site! We believe in leading with diversity, equity, and inclusion. Everyone has a place and a voice in Seattle.

Press release - Medi-Tech Insights - Global Biologics Market Set to Expand at 10-12% CAGR from 2024 to 2029: Medi-Tech Insights - published on openPR.com

Partner with MindWalk to advance biologics discovery through AI, data integration, and lab research—accelerating innovation through collaboration.

Join AGC Biologics' Copenhagen site! On day one, you will join a vibrant community of like-minded individuals in beautiful Denmark.

Resilience announces the acquisition of two biologics manufacturing facilities in North America.

Jan 12, 2026 - For patients with COPD who continue to experience exacerbations with standard therapies, a new generation of biologic drugs can offer significant benefit.

AGC Biologics will provide manufacturing for AAVantgarde’s two therapies designed to address progressive and irreversible vision loss.

AGC Biologics operates multiple cGMP manufacturing lines and a variety of scales in our Heidelberg, Germany facility for microbial, pDNA, and mRNA.

Nov 6, 2025 - AGC Biologics is hiring across our global network. Career opportunities in science, biotech, quality, manufacturing, and more. See our current openings.

AGC Biologics signs service agreement with The Jikei University in Japan for technology transfer and feasibility study for an exosome-based drug product.

With the recent tendency of drug developers to outsource their formulation development services, many CDMOs have adapted to this increased demand by providing...

Drug Safety and Pharmacovigilance for Drugs, Biologics, and Devices Describes the role of drug safety and pharmacovigilance in the development of new drugs,...

ORLANDO — Knowledge of biologic use in pediatric patients with asthma improved among pulmonologists, allergists/immunologists and pediatricians after...

Search results for: "Biologics" - market reports

AGC Biologics expands viral vector and cell therapy clinical stage for Genenta Science's hematopoietic stem cell immuno-oncology program.

Nov 6, 2025 - Find biopharma thought leadership articles and blog posts published by AGC Biologics scientific experts.

AGC Biologics and Immunocore work together in Heidelberg, Germany.

Pharma trainings provide detailed instruction on requirements. At our pharmaceutical trainings you'll have a good overview of relevant regulatory elements.

Jan 17, 2026 - Samsung Biologics zieht als führender Biotech-Auftragshersteller die Aufmerksamkeit der Finanzwelt auf sich. Ist der Hype um die Aktie gerechtfertigt?

Comprehensive protein design, expression, and production services supporting biologics discovery and validation with MindWalk’s AI-lab ecosystem.

Jun 27, 2023 - AbCellera , a DCVC Bio portfolio company searching the immune system for therapeutic antibodies , has teamed up with one of the world’s largest…

Learn about our full range of capabilities as we work in partnership with clients to assemble resources – ours and theirs – to meet manufacturing needs.

Jun 12, 2025 - Turnstone Biologics is a company developing a novel platform of oncolytic viral therapies for cancer.

AGC Biologics can support your technology transfer and is here to partner with you at any of the critical stages in your product's lifecycle.

Oct 1, 2025 - Amgen (Nasdaq: AMGN) recently announced it will invest $650 million to expand its biologics manufacturing facility in Juncos, Puerto Rico.

Find out how biologics work, and how they can help patients with conditions like asthma.

ACG Biologics work included information transfer and master cell bank creation, method implementation, preparation for large-scale manufacturing, and more.

ACG Biologics Milan site has clearances from both U.S. and European regulators to supply patients with HSC-based gene therapy

ORLANDO — Tezepelumab outperformed dupilumab and mepolizumab in specific outcomes for chronic rhinosinusitis with nasal polyps, according to data...

AGC Biologics operates multiple cGMP manufacturing lines and a variety of scales in our Bothell, Washington cell culture facilities.

AGC biologics Colorado | Biopharmaceutical Manufacturing in Colorado

A global contract development manufacturing organization (CDMO/CMO) offering development & manufacturing for protein expression biologics, pDNA, mRNA,...

Dec 8, 2025 - USD 5.5 billion deal: Biocon plans to buy the remaining shares of its subsidiary, Biocon Biologics Limited, by exchanging its own shares. This deal values...

Jul 27, 2023 - Lawmakers heard firsthand accounts of craft that are "beyond our current understanding of our technology," and allegations that the U.S. recovered...

Nov 17, 2025 - Australia’s pioneering asthma researchers are now driving a new frontier: using artificial intelligence and next-generation science to unlock the first...

Pharma trainings provide detailed instruction on requirements. At our pharmaceutical trainings you'll have a good overview of relevant regulatory elements.

Biosimilars cut biologic drug costs by 50% or more, saving patients and the system billions. Learn why they're not more widely used-and how to access them.

Nov 6, 2025 - AGC Biologics is a CDMO offering protein biologics (mammalian, microbial), cell therapies, viral vectors, pDNA & mRNA production & manufacturing...

At Taron Solutions, we specialize in biologics development and GMP manufacturing, offering core strengths that drive innovation and success. As the partner of...

AGC Biologics enhances drug development with real-time Process Analytical Technology (PAT), improving biopharmaceutical manufacturing processes.

Meet the global executive leadership team and the general managers who oversee each of our facilities across the globe.

Resilience continues expansion with acquisition of biologics manufacturing company Ology Bioservices.

Oct 9, 2025 - Comprehensive modeling platform for biologics discovery

A collection of AGC Biologics branding materials including logos, a boilerplate company summary, and our color palette.

Resilience is a biomanufacturing CDMO focused on improving access to complex medicines, with end-to-end solutions for safe and scalable manufacturing.

Oct 2, 2025 - AbbVie (NYSE:ABBV) announced that it began construction for a $70 million expansion of its bioresearch center (ABC) in Worcester, Mass.

Mar 22, 2024 - Biologics are a targeted type of drug and can be a good option for psoriatic arthritis if you haven’t found success with other available treatments. Everyday...

Our Milan facility was the first cell and gene therapy site approved in Europe for GMP manufacturing of clinical and commercial supply.

Learn about MindWalk’s technology collaborations in AI, data, and cloud infrastructure driving innovation and scalability in biologics discovery.

The biopharma CDMO continues mammalian cell culture manufacturing work on Provention Bio type 1 Diabetes treatment, helping with commercial manufacturing.

Resources for consumers on biological products.

Nov 6, 2025 - We celebrate individuality and we encourage expression, authenticity and vulnerability in the workplace.

Partner-ready biologics pipeline built on data integration, AI insights, and lab research—advancing antibody, vaccine, and peptide assets.

Our new multi-purpose, Yokohama facility will provide full cell therapy, mammalian, and mRNA services to meet the growing demand for CDMOs in Japan.

Find MindWalk offices and innovation hubs worldwide leading integrated AI, data, and lab-based biologics discovery efforts.

Dec 1, 2025 - You can face many challenges when shipping biologics. Check out how Cryoport Systems can help with our platform of risk-mitigating services.

Join us at AGC Biologics' Boulder site! The team is a tight-knit group of talented individuals who champion a welcoming and collaborative environment.

Dec 4, 2024 - In recent years, the cell culture company Nucleus Biologics has been at the forefront of market disruption. In this interview with David Sheehan (CEO), we...

Nov 19, 2025 - See how Forge Biologics built a modern intranet with Simpplr to improve access to information, enhance engagement, and support rapid growth.

Oct 24, 2025 - MMIT tracks current and emerging trends about biologics and injectables index. We'll grant your brand insight into the power dynamics between IDNs and...

Our growing biologics portfolio offers solutions in a variety of innovative formats to help provide the best possible patient outcomes.

Jul 16, 2024 - If your asthma is not well-controlled, a biologic medicine may be a treatment option to help you manage your asthma.

Nov 3, 2025 - Samsung Biologics announced today that it completed the spinoff of its Samsung Bioepis unit to focus on leading as a pure-play CDMO.

Library of educational articles, scientific research, and webinars about drug development and manufacturing within the biopharmaceutical industry.

May 29, 2025 - For those who haven't found the right treatment to manage their moderate to severe ulcerative colitis symptoms, biologics may be an alternative solution.

Nov 19, 2025 - HEIDELBERG, Germany – AGC Biologics today announced it is partnering with Repair Biotechnologies to tackle one of the world’s most persistent...

In recent years, there’s been a revolution in DMARDS available, driven largely by genetically engineered proteins that target your immune system.

Le 24 Mars 2022, Catalent Biologics a finalisé un projet de 27 millions d'euros pour la transformation de son site de Limoges en un centre (…)

Unlock the Power of De Novo Protein Engineering with AI

Nov 5, 2025 - Temperature or vibrations can destroy a drug in moments, changing medications into ineffective substances or harmful products. Learn how SpotSee's...

Essential Pharma Partners with AGC Biologics to Accelerate Development and Production of Promising Neuroblastoma Therapy Hu14.18.

Our Boulder, CO facility is a large-scale biopharmaceutical manufacturing facility that houses two 20,000 liter stainless steel mammalian cell bioreactors.

Before you start a biologic drug for inflammatory bowel disease (IBD), you’ll undergo a screening process to evaluate your medical history and current heal

A collection of blogs, news articles and features on biologics for the treatment of musculoskeletal disorders.

At AGC Biologics, our process development experience has attributed to over 200 protein, biologics, and cell and gene therapy processes in the last decade.

Newco Tecregen AG has raised CHF10 million (US$12.5 million) to advance a novel way of regenerating the thymus in order to boost T-cell production and...